What We’re Reading: FTC Lawsuit Against PBMs; Ozempic Price Cuts; Hospital Outpatient Pay Bump
The Federal Trade Commission (FTC) is preparing a lawsuit against the 3 largest drug middlemen over their use of rebates for insulin and other drugs; Sen Bernie Sanders (I, Vermont) feels confident that Novo Nordisk will cut Ozempic and Wegovy costs after hearing; CMS proposed a payment rule that would increase Medicare reimbursement for hospital outpatient departments by 2.6% next year.
FTC Preparing Lawsuit Against PBMs Over Insulin Rebates
The Federal Trade Commission (FTC) is preparing a lawsuit against the 3 largest drug intermediaries over their use of rebates for insulin and other drugs, according to the
Sen Bernie Sanders Optimistic Novo Nordisk Will Cut US Ozempic, Wegovy Costs
Sen Bernie Sanders (I, Vermont), chair of the Senate Committee on Health, Education, Labor, and Pensions (HELP), is optimistic that drug manufacturer Novo Nordisk will cut Ozempic and Wegovy costs after being publicly shamed over how much it charges in the US compared with other countries, according to
Medicare Proposes 2.6% Hospital Outpatient Pay Bump Next Year
CMS proposed a
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025